HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Pregnant patients with cancer face delayed protocols, difficult choices
-
- Adjuvant tamoxifen associated with reduced 15-year risk for breast cancer recurrence, death
- Adult survivors of transplantation for aplastic anemia lived mostly healthy lives
- BRAF inhibitor receives FDA approval for metastatic, unresectable melanoma
- Daughters of BRCA mutation carriers unaware of their breast cancer risk
- FDA awards investigational new drug approval to two cancer vaccines
- FDA grants brentuximab accelerated approval for HL, ALCL
- Pelvic inflammatory disease associated with increased risk for ovarian cancer
- Platinum-based combination therapy improved survival in elderly patients with NSCLC
-
- Restoring PTPN12 function may prevent tumorigenesis in triple-negative breast cancer
- Simvastatin associated with reduced risk for breast cancer recurrence
- Time to first cigarette associated with risk for lung, head and neck cancer
- Women with germline mutations in RAD51D more susceptible to ovarian cancer
- A 41-year-old woman with a transforming lymphoma Amit Mehta, MD
- Intracranial hemorrhage as the initial presentation of gliosarcoma in a young woman Munir Ghesani, MD, FACNM; Lauren Moomjian, MD; Daniel E. Meltzer, MD
- Decrease in hormone therapy use associated with mammography rate decrease in younger women
- Fewer births, breastfeeding reduced risk for ER/PR-negative breast cancer among black women
-
- Increased Vitamin D levels were associated with nonmelanoma skin cancer
- Single flexible sigmoidoscopy reduced colorectal cancer incidence, mortality rates
- Update in pain and supportive care research Biren Saraiya, MD